Limitations in medicaid coverage of biologics for the treatment of hidradenitis suppurativa
Archives of Dermatological Research · 14.09.2024 · 316 (9)
DOI: 10.1007/s00403-024-03371-9 ↗Kurz gefasst
Leserbrief in der Zeitschrift Archives of Dermatological Research, online erschienen am 14.09.2024. Verfasst von Neha Arora und 2 weiteren Autor:innen. Beteiligte Einrichtung: Texas A&M University College of Medicine, Bryan, 3600 Gaston Ave, Dallas, TX, 75246, USA. narora2018@tamu.edu. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa, Biological Products, Medicaid, Insurance Coverage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Texas A&M University College of Medicine, Bryan, 3600 Gaston Ave, Dallas, TX, 75246, USA. narora2018@tamu.edu.
- Texas A&M University College of Medicine, Bryan, 3600 Gaston Ave, Dallas, TX, 75246, USA.
- Department of Dermatology, Baylor Scott & White Medical Center, Temple, TX, USA.
Zitieren
APA
Arora, N., Skaggs, E., & Bicknell, L. (2024). Limitations in medicaid coverage of biologics for the treatment of hidradenitis suppurativa. Archives of Dermatological Research, 316(9). https://doi.org/10.1007/s00403-024-03371-9
Vancouver
Arora N, Skaggs E, Bicknell L. Limitations in medicaid coverage of biologics for the treatment of hidradenitis suppurativa. Archives of Dermatological Research. 2024;316(9). doi:10.1007/s00403-024-03371-9
BibTeX
@article{Arora2024,
author = {Arora, Neha and Skaggs, Elena and Bicknell, Lindsay},
title = {Limitations in medicaid coverage of biologics for the treatment of hidradenitis suppurativa},
journal = {Archives of Dermatological Research},
year = {2024},
volume = {316},
number = {9},
doi = {10.1007/s00403-024-03371-9}
}
EUVIMED